The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): 2m
Expected first date of trading: 24/04/2014
Market: AIM
Location of address at which admission document will be available: A copy of the Company's Admission Document is available for download from the Company's website at www.ad-investments.com and following Admission and change of name at www.tizianalifesciences.com The Admission Document contains full details about the applicant and the admission of its securities.
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): Cairn Financial Advisers LLP
Nominated Broker (AIM Companies): Beaufort Securities Limited

Company details
Name Role
Christopher William Rourke Non-Executive Chairman
Percy William Cecil Lomax Non-Executive Director
David Alexander Hill Scott Non-Executive Director
Andrew Mark Gutmann Non-Executive Director
Gabriele Marco Antonio Cerrone Executive Chairman
Philip James Boyd Finance Director
Riccardo Dalla-Favera Non-Executive Director

Facts and Figures
Fiscal year end: 31 December
Incorporated in: UK
Website URL: www.ad-investments.com To be changed following Admission and change of name to: www.tizianalifesciences.com
space
Description of business:
The Company is proposing to acquire the entire issued share capital of Tiziana Pharma Limited (TPL), which constitutes a reverse takeover under AIM Rule 14 and which, if approved by shareholders, will have the effect of changing the status of the Company from an investing company under the AIM Rules to an operating company with a material trading activity. The so enlarged group's operations would ...

Person(s) interested:
Shareholder Holding before admission Holding after admission Planwise Group Ltd* 25.9% 66.0% Griffin Two Limited 7.0% 0.2% Christopher McGuigan - 3.7% *Gabriele Cerrone, one of the proposed directors, is the ultimate beneficial owner of the entire issued share capital of Planwise Group Ltd.


Alexander David Investments plc (to be renamed Tiziana Life Sciences PLC)

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds